Instrument Inactif

Communiqués Genaera Corporation

Actions

US36867G2093

Recherche biotechnologique et médicale

Cours en clôture Other OTC
- ^USD	-

Communiqués

30/11/-1	GENAERA : to Present at Therapeutic Area Partnerships 2008	PR
30/11/-1	GENAERA : to Present at BIO InvestorForum	PR
30/11/-1	GENAERA : Receives Non-Compliance Notice From NASDAQ	PR
30/11/-1	GENAERA : Corporation Announces Second Quarter Financial Results	PR
30/11/-1	GENAERA : Releases Phase 1 Data and New Preclinical Data on the CNS Function of Trodusquemine (MSI-1436) at CBI Obesity Summit	PR
30/11/-1	GENAERA : Corporation Elects Paul K. Wotton to Board of Directors	PR
30/11/-1	GENAERA : Corporation to Present at BIO Business Forum	PR
30/11/-1	GENAERA : BeaconEquity.com Issues TraderNotes on Biotechnology Stocks: TPIM, RXII, VION, CUR, AMGN, GILD, BIIB, GENR	PR
30/11/-1	GENAERA : Corporation's 2008 Annual Stockholder Meeting Results	PR
30/11/-1	Genaera : Genaera Corporation Announces First Quarter Financial Results	PR
30/11/-1	Genaera : Xmark Comments on Genaera Cost-Saving Plan	PR
30/11/-1	Genaera : Genaera Corporation Announces Initiatives to Conserve Resources to Continue Development Efforts	PR
30/11/-1	Genaera : Genaera Corporation Receives Audit Opinion Containing Going Concern Explanatory Paragraph	PR
30/11/-1	Genaera : Genaera Corporation Announces 2007 Financial Results	PR
30/11/-1	Genaera : Genaera Corporation Announces MSI-1436 Data Presented at Society of Neuroscience Meeting	PR
30/11/-1	Genaera : Genaera Announces MedImmune Initiation of Phase 2a Trial of Antibody Targeting Interleukin-9 in Patients with Asthma	PR
30/11/-1	Genaera : Genaera Corporation to Present at BIO CEO & Investor Conference	PR
30/11/-1	GENAERA CORP COM STK USD0.002 : Genaera Corporation Board of Directors Dissolves Corporation and Forms Liquidating Trust	PR
30/11/-1	GENAERA : Corporation Announces Results of Special Meeting of Stockholders	PR
30/11/-1	GENAERA : Receives Non-Compliance Notice from Nasdaq	PR
30/11/-1	GENAERA : Corporation Announces Approval of Plan of Liquidation and Dissolution by Board of Directors	PR
30/11/-1	GENAERA : Corporation Implements Cash Conservation Plan	PR
30/11/-1	GENAERA : Corporation Receives Audit Opinion Containing Going Concern Explanatory Paragraph	PR
30/11/-1	GENAERA : Corporation Announces 2008 Financial Results	PR
30/11/-1	GENAERA : Presents Preliminary Phase 1b Data for Trodusquemine (MSI-1436)	PR